We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Biosensor Monitors Glucose in Tears and Sweat

By LabMedica International staff writers
Posted on 06 Feb 2018
Print article
Image: The biosensor uses nanoribbons of indium oxide, an enzyme glucose oxidase, a natural chitosan film and single-walled carbon nanotubes to track glucose levels (Photo courtesy of University of Southern California).
Image: The biosensor uses nanoribbons of indium oxide, an enzyme glucose oxidase, a natural chitosan film and single-walled carbon nanotubes to track glucose levels (Photo courtesy of University of Southern California).
The diagnosis and tracking medical conditions are often done by analyzing a sample of blood. The pain of pricking fingers or drawing blood, however, can deter people from vigilantly monitoring conditions such as diabetes that require regular checks.
 
The use of wearable sensors are part of an increasingly digitized world. An ultra-thin, flexible sensor has been developed that could be incorporated into contact lenses or on the backs of watches for real-time glucose tracking.
 
Scientists at the University of Southern California (Los Angeles, CA, USA) and their colleagues created a biosensor using nanoribbons of indium oxide, an enzyme glucose oxidase, a natural chitosan film and single-walled carbon nanotubes. When glucose is present in a test sample, it interacts with the enzyme, setting off a short chain of reactions and ultimately creating an electrical signal.
 
Testing showed that the device could detect a range of glucose concentrations from 10 nanomolar to 1 millimolar, which is sensitive enough to cover typical glucose levels in sweat, saliva and tears in people with and without diabetes. Bending the film 100 times did not noticeably affect its performance. The shadow-mask-fabricated devices show good electrical performance with gate voltage applied using a gold side gate electrode and through an aqueous electrolyte.
 
The biosensor aims to track glucose levels through tears and sweat and could be incorporated into contact lenses or watches for real-time monitoring. The authors concluded that their high-performance indium oxide (In2O3) nanoribbon sensing platform has great potential to work as indispensable components for wearable healthcare electronics. The study was published on January 17, 2018, in the journal ACS Nano.
 
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.